← Back to patent-cliff list
CAS 1401069-79-1
4-(2-((2E,3E)-1,1,1-trifluoro-4-(p-tolyl)but-3-en-2-ylidene)hydrazinyl)benzenesulfonamide
Codes: CELE-009
Application context (from source-drug indications)
PainCelecoxibInflammatory diseaseCelecoxib关节周围炎Celecoxib肌腱炎Celecoxib颈肩腕综合征CelecoxibLow back painCelecoxib
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Celecoxib | Tier B — Position early | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
4-(2-((2E,3E)-1,1,1-trifluoro-4-(p-tolyl)but-3-en-2-ylidene)hydrazinyl)benzenesulfonamide
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.